<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01647997</url>
  </required_header>
  <id_info>
    <org_study_id>Lsne-128/01</org_study_id>
    <nct_id>NCT01647997</nct_id>
  </id_info>
  <brief_title>Lactate Metabolism After an Endotoxin Challenge in Healthy Humans</brief_title>
  <official_title>Effects of an Acute Administration of Bacterial Endotoxin on Whole Body and Regional Lactate Metabolism in Healthy Male Volunteers</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Lausanne</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Centre Hospitalier Universitaire Vaudois</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Lausanne</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Sepsis is characterized by hyperlactatemia, the severity of which is proportionate with
      sepsis severity. The pathophysiological mechanisms (increased lactate production vs decreased
      lactate utilization; tissues involved in sepsis-induced lactate production) remain largely
      unknown.

      In this study, the investigators will assess whole body and regional metabolism in healthy
      young male subjects on two occasions, once after administration of an intravenous bacterial
      endotoxin challenge, and once without intervention.

      In one group of subjects, whole body lactate metabolism will be measured over 10 hours after
      the endotoxin challenge

        -  Energy expenditure and net substrate oxidation rates (indirect calorimetry)

        -  Lactate kinetics (measured by means of a continuous, exogenous sodium lactate infusion)

        -  Glucose kinetics (measured with 6,6 d2 glucose)

        -  Hemodynamic parameters and body temperature

        -  Blood clinical chemistry In one group of subjects, whole body lactate metabolism will be
           measured over 10 hours after the endotoxin challenge

        -  Energy expenditure and net substrate oxidation rates (indirect calorimetry)

        -  Lactate kinetics (measured by means of a continuous, exogenous sodium lactate infusion)

        -  Glucose kinetics (measured with 6,6 d2 glucose)

        -  Hemodynamic parameters and body temperature

        -  Blood clinical chemistry

      In a second group of subjects, regional muscle lactate metabolism will be measured over 10
      hours after the endotoxin challenge by means of muscle microdialysis
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>April 2002</start_date>
  <completion_date type="Actual">December 2004</completion_date>
  <primary_completion_date type="Actual">March 2004</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Whole body lactate production</measure>
    <time_frame>single bacterial endotoxin administration; measurements over 6.5 hours following administration</time_frame>
    <description>Whole body lactate clearance will be measured by measuring the increase in blood lactate at steady state during a conrtinuous exogenous sodium lactate infusion.
Lactate production will be calculated as the product of lactate clearance times per-infusion blood lactate concentration</description>
  </primary_outcome>
  <primary_outcome>
    <measure>skeletal muscle lactate concentration</measure>
    <time_frame>single bacterial endotoxin administration; measurements over 6.5 hours following administration</time_frame>
    <description>interstitial muscle measured by means of in vivo microdialysis ; calculation of muscle-blood lactate gradient</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>whole body energy expenditure</measure>
    <time_frame>single bacterial endotoxin administration; measurements over 6.5 hours following administration</time_frame>
    <description>open circuit indirect calorimetry (hood)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>body temperature</measure>
    <time_frame>single bacterial endotoxin administration; measurements over 6.5 hours following administration</time_frame>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">14</enrollment>
  <condition>Sepsis</condition>
  <arm_group>
    <arm_group_label>study 1a</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>whole body lactate production after bacterial endotoxin challenge</description>
  </arm_group>
  <arm_group>
    <arm_group_label>study 1b</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>basal whole body lactate production</description>
  </arm_group>
  <arm_group>
    <arm_group_label>study 2a</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>muscle lactate concentration after bacterial endotoxin challenge</description>
  </arm_group>
  <arm_group>
    <arm_group_label>study 2b</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>basal muscle lactate concentrations</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>bacterial endotoxin challenge</intervention_name>
    <description>iv administration of 2ng/kg bacterial endotoxin</description>
    <arm_group_label>study 1a</arm_group_label>
    <arm_group_label>study 2a</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  gender male

          -  body mass index (BMI) &lt; 25 kg/m2

          -  absence of known disease

        Exclusion Criteria:

          -  any known pathology

          -  abnormal cardio-pulmonary and hemodynamic status

          -  electrocardiographic alterations

          -  history of allergy

          -  current medications

          -  drug abuse

          -  consumption of more than 20g/day alcohol
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>30 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ren√© Chiolero, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Centre Hospitalier Universitaire Vaudois</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Centre Hospitalier Universitaire Vaudois</name>
      <address>
        <city>Lausanne</city>
        <state>Vaud</state>
        <zip>CH-1011</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>July 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 17, 2012</study_first_submitted>
  <study_first_submitted_qc>July 19, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 24, 2012</study_first_posted>
  <last_update_submitted>July 19, 2012</last_update_submitted>
  <last_update_submitted_qc>July 19, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 24, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Lausanne</investigator_affiliation>
    <investigator_full_name>Luc Tappy, MD</investigator_full_name>
    <investigator_title>Professor of Physiology</investigator_title>
  </responsible_party>
  <keyword>bacterial lipopolysaccharides</keyword>
  <keyword>hyperlactatemia</keyword>
  <keyword>muscle lactate</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

